The Pacific Northwest Node of the NIDA Clinical Trials Network (CTN) is delighted to announce that in March 2018, Dr. Mary Hatch-Maillette was named Co-Director of the Pacific Northwest Node. Having joined the University of Washington’s Alcohol & Drug Abuse Institute in 2003 to work on CTN-0018, Safer Sex for Men, she has since held a variety of local and national roles in seven additional CTN protocols and two platform studies, including the BEing Safe in Treatment (BEST) study. In addition, she maintains a private psychotherapy practice in Seattle. Her primary research interests are in substance use treatment and HIV risk behavior.
Now one of the longest-serving members of the Pacific Northwest Node and a CTN “veteran,” Dr. Hatch-Maillette has co-authored 45 papers, posters, and presentations for the CTN. She is excited to join the CTN leadership and continue the PNW Node’s tradition of blending science and practice in the treatment of substance use disorders.